Less‐invasive diagnosis of disseminated epithelioid glioblastoma harboring BRAF V600E mutation by cerebrospinal fluid analysis—A case report

Spinal dissemination in epithelioid glioblastoma can be diagnosed by cerebrospinal fluid cytology and liquid biopsy to detect BRAF V600E mutation. Spinal dissemination in epithelioid glioblastoma can be diagnosed by cerebrospinal fluid cytology and liquid biopsy to detect BRAF V600E mutation.

Saved in:
Bibliographic Details
Published inClinical case reports Vol. 9; no. 7
Main Authors Natsumeda, Manabu, Kanemaru, Yu, Kawaguchi, Yukie, Umezu, Hajime, Kakita, Akiyoshi, Fujii, Yukihiko
Format Journal Article
LanguageEnglish
Published Bognor Regis John Wiley & Sons, Inc 01.07.2021
John Wiley and Sons Inc
Wiley
Subjects
Biopsy
BRAF V600E
Brain cancer
Case Report
Case Reports
Cellular biology
Cerebrospinal fluid
cytology
Cytoplasm
epithelioid glioblastoma
less‐invasive
liquid biopsy
Lymphoma
Medical prognosis
Melanoma
Metastasis
Mutation
Nervous system
Patients
Pediatrics
Plasma
Tumors
Online AccessGet full text

Cover

More Information
Summary:Spinal dissemination in epithelioid glioblastoma can be diagnosed by cerebrospinal fluid cytology and liquid biopsy to detect BRAF V600E mutation. Spinal dissemination in epithelioid glioblastoma can be diagnosed by cerebrospinal fluid cytology and liquid biopsy to detect BRAF V600E mutation.
Bibliography:Funding information
The study is supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science Grant number: 19K09476
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.4551